Medicine and Dentistry
Wart Virus
100%
Cervical Cancer Screening
62%
Cervical Cancer
56%
Cost-Effectiveness Analysis
43%
Health Care Cost
35%
Wart Virus Vaccine
31%
Cytotechnology
28%
Malignant Neoplasm
25%
Colposcopy
24%
Papanicolaou Stain
23%
Human Immunodeficiency Virus
17%
Ovarian Cancer
17%
Papillomavirus Infection
17%
Clinician
16%
Screening
13%
Cervical Intraepithelial Neoplasia
13%
Cancer Mortality
12%
Neoplasm
12%
Breast Cancer
12%
Lifespan
11%
Adolescence
11%
Prevalence
11%
Disease
11%
Triage
10%
Infection
10%
Quality Adjusted Life Year
9%
Sensitivity and Specificity
9%
Health Care
8%
Human Papillomavirus Type 16
8%
Clinical Pathology
8%
Screening Test
8%
Cross Sectional Study
8%
Cancer Diagnosis
7%
False Positive Result
7%
Cancer Therapy
6%
Cancer
6%
Hysterectomy
6%
Systematic Review
6%
Cancer Incidence
6%
Life Expectancy
5%
Cervical Cancer Prevention
5%
Squamous Cell
5%
Quality of Life
5%
Positron Emission Tomography
5%
Staphylococcus Aureus
5%
Chlamydiae
5%
Pertussis
5%
Diseases
5%
Health Care Provider
5%
Biopsy Technique
5%
Keyphrases
Cervical Cancer Screening
64%
Human Papillomavirus Vaccine
48%
Cervical Cancer
47%
High-risk Human Papillomavirus (HR-HPV)
40%
Human Papillomavirus Testing
39%
Minnesota
30%
Colposcopy
24%
Cost-effectiveness Analysis
23%
Cost-effectiveness
22%
Papillomavirus Infections
20%
Ovarian Cancer
17%
Vaccination
17%
United States
16%
Pap Test
16%
Screening Strategy
15%
Natural History
14%
Cervical Neoplasia
13%
Vaccine Uptake
12%
Quality-adjusted Life Years
11%
Cervical Intraepithelial Neoplasia
10%
Cancer Mortality
10%
Pertussis
9%
Breast Cancer
9%
HPV16
9%
Oncogenic Human Papillomavirus
9%
Screening Guidelines
8%
People Living with HIV (PLHIV)
8%
Clinical Pathology
8%
Screening Test
8%
Young Women
8%
Self-collected
8%
Incremental Cost-effectiveness Ratio
8%
Screening Interval
8%
Triage
8%
Cervical Cancer Incidence
8%
HPV Vaccine
8%
Cervical Pathology
7%
Early Detection of Cervical Cancer
7%
American Cancer Society
7%
American Society
7%
Ovarian Cancer Screening
7%
Tanzania
7%
Cervical Cancer Prevention
7%
Lifesaving
7%
Atypical Squamous Cells of Undetermined Significance (ASC-US)
7%
Confidence Interval
7%
Self-collection
7%
Healthcare Professionals
6%
Screening Program
6%
Ghana
6%